-
FEBRASGO POSITION STATEMENT11-25-2024
Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in women: diagnosis and treatment: Number 11 – 2024
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS11
Abstract
FEBRASGO POSITION STATEMENTNonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in women: diagnosis and treatment: Number 11 – 2024
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS11
-
FEBRASGO POSITION STATEMENT11-14-2024
Challenges and strategies in adolescent vaccination: Number 12 – 2024
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS12
Abstract
FEBRASGO POSITION STATEMENTChallenges and strategies in adolescent vaccination: Number 12 – 2024
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-FPS12
-
Letter to the Editor10-23-2024
The gynecologist and cancer in women
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo92
Abstract
Letter to the EditorThe gynecologist and cancer in women
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo92
Views196Cervical cancer continues to claim an alarming number of victims around the world, especially among poor women. In Brazil, in 2022, an incidence of 16.3/100,000 women was recorded,() with a projection for 2023 of 17,010 new cases, corresponding to a rate of 15.38/100,000, representing 7% of tumors in women.In the Brazilian reality, where there is […]See more -
Original Article10-23-2024
Nipple-sparing mastectomy in young versus elderly patients
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo90
Abstract
Original ArticleNipple-sparing mastectomy in young versus elderly patients
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo90
Views218See moreAbstract
Objective:
In this study, we compared indications and outcomes of 115 young (< 40 years) versus 40 elderly (> 60 years) patients undergoing nipple-sparing mastectomy (NSM) as risk-reducing surgery or for breast cancer (BC) treatment.
Methods:
Between January 2004 and December 2018, young and elderly patients undergoing NSM with complete data from at least 6 months of follow-up were included.
Results:
BC treatment was the main indication for NSM, observed in 85(73.9%) young versus 33(82.5%) elderly patients, followed by risk-reducing surgery in 30(26.1%) young versus 7(17.5%) elderly patients. Complication rates did not differ between the age groups. At a median follow-up of 43 months, the overall recurrence rate was higher in the younger cohort (p = 0.04). However, when stratified into local, locoregional, contralateral, and distant metastasis, no statistical difference was observed. During the follow-up, only 2(1.7%) young patients died.
Conclusion:
Our findings elucidate a higher recurrence rate of breast cancer in younger patients undergoing NSM, which may correlate with the fact that age is an independent prognostic factor. High overall survival and low complication rates were evidenced in the two groups showing the safety of NSM for young and elderly patients.
-
Original Article10-23-2024
Access and adequacy of antenatal care in a city in Brazil during two phases of the COVID-19 pandemic
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo87
Abstract
Original ArticleAccess and adequacy of antenatal care in a city in Brazil during two phases of the COVID-19 pandemic
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo87
Views255Abstract
Objective:
To compare access and suitability of antenatal care between years 2020 and 2022 among postpartum individuals at a Hospital in Florianopolis, and evaluate factors associated with antenatal suitability.
Methods:
Observational, cross-sectional, and quantitative study carried out in 2022. Collected data were compared with the database of a previous similar study carried out in the same setting in 2020. Data were extracted from medical records and prenatal booklets, in addition to a face-to-face questionnaire. Adequacy was measured using the Carvalho and Novaes index and health access was qualitatively evaluated. Socio-demographic and antenatal variables were analyzed. A statistical significance level of 0.05 was considered. Open-ended questions were categorized for analysis.
Results:
395 postpartum individuals were included. Antenatal care was adequate for 48.6% in 2020 and 69.1% in 2022. Among the barriers to access, 56% reported difficulty in scheduling appointments and/or exams and 23% complained of reduced healthcare staff due to strikes, COVID-19, among others. Adequate antenatal care was associated with being pregnant in 2022, being referred to high-risk units (PNAR), and not reporting difficulties in access. Also, it was associated with twice the chance of investigation for gestational diabetes (GDM) and syphilis.
Conclusion:
The 2022 post-vaccination period showed higher antenatal adequacy. The main difficulty for postpartum individuals was scheduling appointments and/or exams. Having antenatal care in 2022, no reports of difficulty in access, and follow-up at a high-risk unit were associated with antenatal adequacy.
Key-words COVID-19Delivery of health careDiabetesGestationalpandemicsPostpartum periodPregnancyPrenatal caresurveys and questionnairesVaccinationSee more -
Original Article10-23-2024
The role of HIV as an independent risk factor to cervical HSIL recurrence
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo85
Abstract
Original ArticleThe role of HIV as an independent risk factor to cervical HSIL recurrence
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo85
Views359ABSTRACT
Objective:
To evaluate the role of being human immunodeficiency virus (HIV) positive for predicting the risk of recurrence in women with a cervical high grade squamous intraepithelial lesion (HSIL) diagnosis.
Methods:
Retrospective observational case-control study, comprising HIV positive (case) and HIV negative (control) women in a 1:4 ratio. Women assisted by the Erasto Gaertner Hospital, between 2009-2018, with cervical HSIL diagnosis, submitted to treatment by Loop electrosurgical excision procedure (LEEP), and with a minimum follow-up of 18 months, were included. The immunological status, number and time to recurrence were analyzed, with p<0.05 considered significant. In a second analysis, only patients with free margins were evaluated.
Results:
The sample consisted of 320 women (64 cases and 256 controls). Presence of HIV, CD4 levels <200 and detectable viral load (CV) were associated with high risk of recurrence, with odds ratio (OR) of 5.4 (p<0.001/95CI:2.8-10); 3.6 (p<0.001 /IC95:0.6-21.1) and 1.8 (p=0.039 /IC95:0.3-9.3), respectively. In the sample with free margins (n=271), this risk was also higher among seropositive patients, with OR 4.18 (p=0.001/95CI:1.8-9.2).
Conclusion:
HIV is an independent risk factor for cervical HSIL recurrence and reduced disease-free survival time. Glandular involvement, compromised margins, undetectable CV and CD4<200 also increase the risk of relapse.
Key-words Disease-free survivalElectrosurgeryExcision marginsHIV infectionsRecurrenceRisk factorsSquamous intraepithelial lesionsUterine cervical neoplasmsSee more -
Original Article10-23-2024
Assessment of risk factors associated with post-molar gestational trophoblastic neoplasia: a retrospective cohort
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo83
Abstract
Original ArticleAssessment of risk factors associated with post-molar gestational trophoblastic neoplasia: a retrospective cohort
Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo83
Views221ABSTRACT
Objective:
Evaluate the risk factors for the development of post-molar gestational trophoblastic neoplasia.
Methods:
Retrospective cohort study with 320 women with gestational trophoblastic disease (GTD) followed in a tertiary hospital from January 2005 to January 2020. Data referring to the women’s sociodemographic profile, clinical, laboratory and treatment aspects and types of GTD were analyzed.
Results:
The mean age of women with the benign form was 26.4±8.6 years and with the malignant forms 26.9±8.5 years (p=0.536). Most women with malignant forms came from regions further away from reference center (p=0.012), had vesicle elimination at the time of diagnosis (p=0.028) and needed more than one uterine evacuation (p<0.001) when compared to the benign forms. There was no difference between laboratory tests in both forms. Being between 30 and 39 years old increased the chance of developing invasive mole by 2.5 (p=0.004; 95%CI:1.3–4.9) and coming from regions far from reference center by 4.01 (p=0.020; CI95%: 1.2-12.9). The women with the highest risk of malignant forms were those with the longest time of become normal on human gonadotrophic hormone (hCG) testing (each week the risk increases 1.3 times; p<0.001, 95%CI: 1.2-1.3).
Conclusion:
The prolonged hCG fall curve is the main indicator of an increased chance of GTN. Women from regions further away from reference center have a greater chance of developing malignant forms, probably due to the difficulty in accessing the reference center and, therefore, adequate follow-up that would allow early identification of more serious cases.
Key-words Gestational trophoblastic diseaseGestational trophoblastic neoplasmHydatidiform mole, invasiveSee more
-
Original Article07-02-2009
Depression and anxiety in menopausal women: associated factors
Revista Brasileira de Ginecologia e Obstetrícia. 2009;31(3)
Abstract
Original ArticleDepression and anxiety in menopausal women: associated factors
Revista Brasileira de Ginecologia e Obstetrícia. 2009;31(3)
-
Original Article03-15-2012
Influência da percepção dos profissionais quanto ao aborto provocado na atenção à saúde da mulher
Revista Brasileira de Ginecologia e Obstetrícia. 2012;34(2):69-73
Abstract
Original ArticleInfluência da percepção dos profissionais quanto ao aborto provocado na atenção à saúde da mulher
Revista Brasileira de Ginecologia e Obstetrícia. 2012;34(2):69-73
DOI 10.1590/S0100-72032012000200005
Views75See moreOBJETIVO: Identificar o conhecimento e a percepção dos profissionais da saúde em relação à legislação brasileira sobre o aborto provocado. MÉTODOS: Envelopes selados não identificados contendo os questionários foram enviados a todos os profissionais (n=149) que trabalham no Departamento de Obstetrícia de hospital universitário e de hospital público da periferia de São Paulo. Responderam ao questionário 119 profissionais. Para análise dos dados, utilizou-se intervalo de confiança de 0,05 e os testes exatos de Fischer e χ². RESULTADOS: Dos profissionais entrevistados, 48,7% eram médicos, 33,6% profissionais da área de enfermagem e 17,6% eram profissionais de outras áreas (psicólogos, nutricionistas, fisioterapeutas, administrativos e técnicos de laboratórios). Constatou-se diferença significativa (p=0,01) na proporção de profissionais que acreditam que o aborto por malformação fetal não letal e no aborto decorrente de gestações não planejadas deveriam ser incluídos na legislação brasileira. Observou-se que o conhecimento da legislação e da descrição das situações permitidas por lei acerca do aborto foi significativamente diferente na comparação entre os profissionais de saúde (p=0,01). Quando questionados sobre as situações em que a legislação brasileira permite o aborto, observou-se que 32,7% dos médicos, 97,5% profissionais da área de enfermagem e 90,5% dos demais profissionais desconhecem a legislação vigente. CONCLUSÃO: Neste estudo, evidenciou-se o desconhecimento dos profissionais de saúde com relação à legislação brasileira, em menor proporção entre obstetras e em maior proporção entre os profissionais da área de enfermagem. Foram constatadas atitudes de discriminação, julgamento e preconceito na assistência prestada às mulheres que provocam o aborto.
-
Original Article07-20-2004
Evaluation of alternative methods in cervical screening: HPV DNA detection and visual inspection
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(4):269-275
Abstract
Original ArticleEvaluation of alternative methods in cervical screening: HPV DNA detection and visual inspection
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(4):269-275
DOI 10.1590/S0100-72032004000400002
Views16See moreOBJECTIVE: to evaluate the performance of Pap smear, hybrid capture II (HC II), and visual inspection with acetic acid in the detection of pre-invasive and invasive cervical lesions. METHODS: a total of 2281 women were submitted to a clinical exam, including Pap smear, HC II for HPV DNA detection and visual inspection with 5% acetic acid (VIA). When at least one of the tests was positive, colposcopy was performed and targeted biopsies were taken from suspicious lesions. Colposcopy was also performed in 420 women with negative results. Test performance was evaluated, using colposcopy as the gold standard, with or without biopsy. RESULTS: Pap smear, VIA and HC II were positive in 9.2, 10.9 and 17.5% of all women screened, respectively. Although at least one positive test was found in 671 women (29.4%), only 82 (3.6%) presented histologically confirmed disease (50 NIC1, 20 NIC2, 7 NIC3, and 5 invasive carcinoma). VIA and HC II sensitivities were similar and significantly higher than Pap smear. Pap smear showed better specificity than VIA and than HC II. In women with a negative Pap smear result, VIA showed better performance than HC II. CONCLUSION: Pap smear combined with VIA performed better than Pap smear combined with HC II or than Pap smear alone.
-
02-13-2002
Efeito das Drogas Anti-Retrovirais sobre as Taxas de Fertilidade de Ratas Wistar
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(9):630-630
-
Letter to the Editor08-26-2005Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(5):293-293
Abstract
Letter to the EditorRevista Brasileira de Ginecologia e Obstetrícia. 2005;27(5):293-293
Search
Search in:
Tag Cloud
Pregnancy (252)Breast neoplasms (104)Pregnancy complications (104)Risk factors (103)Menopause (88)Ultrasonography (83)Cesarean section (78)Prenatal care (71)Endometriosis (70)Obesity (61)Infertility (57)Quality of life (55)prenatal diagnosis (51)Women's health (48)Maternal mortality (46)Postpartum period (46)Pregnant women (45)Breast (44)Prevalence (43)Uterine cervical neoplasms (43)